Abstract
This study sought to detect the Class A extended-spectrum beta-lactamases (ESBLs) present in Pseudomonas aeruginosa from clinical samples using molecular methods. Twenty-seven P. aeruginosa isolates were characterized among one hundred and fifty clinical samples obtained from three major hospitals in Ogun State. Twenty-five isolates were found to be ESBL producers upon phenotypic screening. DNA was extracted using Zymo DNA extraction kit. Polymerase chain reaction was used to amplify the ESBL genes using specific primers for the CTX-M, SHV, and TEM genes. Agarose gel electrophoresis was used to resolve the amplicons, and they were visualized with a UV transilluminator, 64% (16 isolates) were found positive for TEM, 52 and (13 isolates) for SHV, and 44% (11 isolates) for CTX-M. Some isolates were found positive for two or more of the screened genes. This research identifies the need for surveillance of ESBL producers within Ogun state.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adesina T, Nwinyi O, De N, Akinnola O, Omonigbehin E (2019) First detection of carbapenem-resistant escherichia fergusonii strains harbouring beta-lactamase genes from clinical samples. Pathogens 8(4):164
Agbo MC, Ezeonu IM, Odo MN et al (2019) Phenotypic and molecular characterization of extended spectrum β-lactamase producing Pseudomonas aeruginosa in Nigeria. African J Biotechnol 18(32):1083–1090
Ahmad M, Hassan M, Khalid A et al (2016) ‘Prevalence of Extended Spectrum β-Lactamase and Antimicrobial Susceptibility Pattern of Clinical Isolates of Pseudomonas from Patients of Khyber Pakhtunkhwa, Pakistan’. BioMed Res Int. Hindawi Limited
Ajibade O, Oladipo EK, Aina KT et al (2019) ‘Incidence of Pseudomonas aeruginosa Resistance in Clinical Isolates from Selected Hospitals in Oyo State, Nigeria’. Appl Microbiol 5(2)
Akinduti P, Obafemi YD, Isibor PO et al (2021) Antibacterial kinetics and phylogenetic analysis of Aloe vera plants. Open Access Maced J Med Sci 9(A): 946-954
Ayepola OO, Olasupo LA, Egwari LO, Schaumburg F (2018) Characterization of panton-valentine leukocidin-positive staphyloccoccus aureus from skin and soft tissue infections and wounds in Nigeria: A cross-sectional study. F1000Res 7:1155
Elhariri M, Hamza D, Elhelw R et al (2017) ‘Extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa in camel in Egypt: Potential human hazard’. Ann Clin Microbiol Antimicrob 16(1):21.
Esohe A, Oronsaye F, Omorodion N et al (2017) ‘Presence of bla TEM and bla SHV Genes in ESBLs Producing Klebsiella Pneumonia among Female Patients in University of Benin Teaching Hospital’. 724.
Hosu MC, Vasaikar SD, Okuthe GE et al (2021) ‘Detection of extended spectrum beta-lactamase genes in Pseudomonas aeruginosa isolated from patients in rural Eastern Cape Province, South Africa’. Sci Rep 11(1):7110
Jesumirhewe C, Springer B, Allerberger F et al (2020) ‘Whole genome sequencing of extended-spectrum β-lactamase genes in Enterobacteriaceae isolates from Nigeria’. PLoS ONE 15(4)
Jombo G, Springer B, Allerberger F et al (2010) ‘Multidrug resistant Pseudomonas aeruginosa infections complicating surgical wounds and the potential challenges in managing post–operative wound infections: University of Calabar Teaching Hospital experience’. Asian Pac J Trop Med 3(6):479–482
Kang CI, Kim SH, Kim HB et al (2003) ‘Pseudomonas aeruginosa bacteremia: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome’. Clin Infect Dis 37(6):745–751
Kaur, A. and Singh, S. (2018) ‘ Prevalence of Extended Spectrum Betalactamase (ESBL) and Metallobetalactamase (MBL) Producing Pseudomonas aeruginosa and Acinetobacter baumannii Isolated from Various Clinical Samples ’. J Pathog 1–7.
Khan, F., Khan, A. and Kazmi, SU. (2014) ‘Prevalence and susceptibility pattern of multi drug resistant clinical isolates of Pseudomonas aeruginosa in Karachi’. Pakistan J Med Sci 30(5):951
Khan JA, Iqbal Z, Rahman SUR (2008) ‘Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.’. Pak J Pharm Sci 21(3):311–5.
Kpoda DS, Ajayi A, Somda M et al (2018) ‘Distribution of resistance genes encoding ESBLs in Enterobacteriaceae isolated from biological samples in health centers in Ouagadougou, Burkina Faso’. BMC Res Notes 11(1):471
Madaha EL, Gonsu HK, Bughe RN et al (2020) ‘Occurrence of blaTEM and blaCTXM Genes and Biofilm-Forming Ability among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii in Yaoundé, Cameroon’. Microorganisms 8(5):708
Murakami K, Minamide W, Wada, K et al (1991). Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J clin microbiol 29(10):2240-2244.
Naziri Z, Derakhshandeh A, Soltani BA, (2020) ‘Treatment Failure in Urinary Tract Infections: A Warning Witness for Virulent Multi-Drug Resistant ESBL- Producing Escherichia coli’. Infect Drug Resist 13:1839–1850
Ogbolu DO, Ogunledun A, Adebiyi OE et al (2008) ‘Antibiotic susceptibility patterns of Pseudomonas aeruginosa to available antipseudomonal drugs in Ibadan, Nigeria.’. Afr J Med Med Sci 37(4):339–44
Ogbolu DO, Terry AOA, Webber MA et al (2018) ‘CTX-M-15 is established in most multidrug-resistant uropathogenic Enterobacteriaceae and Pseudomonaceae from hospitals in Nigeria’. Eur J Microbiol Immunol 8(1):20–24
Oli AN, Eze DE, Gugu TH et al (2017) ‘Multi-antibiotic resistant extended-spectrum beta-lactamase producing bacteria pose a challenge to the effective treatment of wound and skin infections’, Pan Afr Med J 27:1–12
Pachori P, Gothalwal R and Gandhi P. (2019) ‘Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review’. Genes Dis 6(2):109–119
Pérez A, Gato E, Pérez-Llarena J et al (2019) ‘High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial’. J Antimicrob Chemother 74(5):1244–1252
Rezai MS, Ahangarkani F, Rafiei A (2018) ‘Extended-Spectrum Beta-Lactamases Producing Pseudomonas aeruginosa Isolated From Patients With Ventilator Associated Nosocomial Infection’. Arch Clin Infect Dis 13(4)
Shaikh S, Fatima J, Shakil S et al (2015) ‘Prevalence of multidrug resistant and extended spectrum beta-lactamase producing Pseudomonas aeruginosa in a tertiary care hospital’, Saudi J Biol Sci 22(1):62–64
Shi Q, Huang C, Xiao T et al (2019). A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: Prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections. Anti Resist Infect Control 8(1):68
Acknowledgments
The authors would like to acknowledge the support of Covenant University Center for Research, Innovation, and Development (CUCRID).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ohore, H.U., Akinduti, P.A., Ahuekwe, E.F., Ajayi, A.S., Olasehinde, G.I. (2022). Molecular Detection of ESBLs, TEM, SHV, and CTX-M in Clinical Pseudomonas aeruginosa Isolates in Ogun State. In: Ayeni, A.O., Sanni, S.E., Oranusi, S.U. (eds) Bioenergy and Biochemical Processing Technologies. Green Energy and Technology. Springer, Cham. https://doi.org/10.1007/978-3-030-96721-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-96721-5_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-96720-8
Online ISBN: 978-3-030-96721-5
eBook Packages: EnergyEnergy (R0)